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Methicillin-resistant Staphylococcus aureus (MRSA), is one of the most prevalent
clinical pathogens isolated from hospital settings, and has increasingly identified in
community settings. In China, the SCCmecIII-ST239 strains are disseminated in different
geographic regions, accounting for >75% of all MRSA isolates in some national
studies. Here we characterized 150 non-duplicate MRSA isolates collected from
February 2012 to May 2013 in a tertiary hospital in Suzhou, Eastern China, to explore
the molecular epidemiology. All isolates were characterized by spa typing, SCCmec
typing, and detection of genes encoding Panton-Valentine leukocidin (PVL) and toxic
shock syndrome toxin (TSST-1). Representative genotypes were also subjected to
multilocus sequence typing (MLST). Antibiotic susceptibility testing was performed using
BD PhoenixTM Automated Microbiology System. Molecular typing identified 11 clonal
complex (CC) and 28 spa types, with the CC5-spa t002 (29.3%) and CC239-spa t037
(14.7%) being the most prevalent. SCCmec types II, III, IV, and V were identified in 33.3,
21.3, 23.3, and 21.3% of all isolates, respectively. PVL genes (lukF/S-PV ) were detected
in 11.3% of all isolates and from 6 CCs (5, 8, 59, 88, 239, and 398). The TSST-1 gene
(tst) was detected in 18.0% of the all isolates, predominantly in CC5 (96.3%). All the
tst-1-positve CC5 isolates were spa t002. Eighteen patients died within 30 days of
hospitalization, and the in-hospital 30-day mortality was 12.0%. Multivariable analysis
showed that 60 years old (odds ratio [OR] = 7.2, P = 0.026), cancer diagnosis (OR
= 9.6, P = 0.022), and MRSA isolate carriage of tst-1 (OR = 62.5, P < 0.001) were
independent factors associated with 30-day mortality. Our study revealed unique MRSA
dissemination patterns in our hospital in comparison to those of other regions in China.
The finding that tst-1-positive CC5 strains were associatedwith higher mortality highlights
the need for strict infection control measures in order to prevent further spread of these
strains in our hospital, as well as others.
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INTRODUCTION
Staphylococcus aureus (S. aureus) is one of the most prevalent
clinical pathogens isolated from hospital settings, and has
recently become widespread in community settings as well.
S. aureus causes a broad variety of diseases including skin
and soft-tissue infections, bacteremia, osteomyelitis, infective
endocarditis, and necrotizing pneumonia (Lowy, 1998; Nadig
et al., 2010; Tokajian et al., 2010; Song et al., 2013). Following its
emergence in the early 1960s, methicillin-resistant Staphylococcus
aureus (MRSA) has become highly epidemic in many hospitals
and health care settings worldwide. Moreover, in recent years
distinct community-acquired MRSA (CA-MRSA) strains have
also emerged as a cause of invasive and life-threatening infections
among young, healthy patients with no significant healthcare
exposure (Deleo et al., 2010; Tokajian et al., 2010; Alon et al.,
2011; Mediavilla et al., 2012; El-Mahdy et al., 2013).
Molecular typing techniques are routinely used to explore
the evolution and epidemiology of MRSA, the most commonly-
used being staphylococcal protein A (spa) typing (Shopsin
et al., 1999; Harmsen et al., 2003), staphylococcal cassette
chromosome (SCC) mec typing (International Working Group
on the Classification of Staphylococcal Cassette Chromosome
Elements, 2009), multilocus sequence typing (MLST) (Enright
et al., 2000), pulsed-field gel electrophoresis (PFGE) (Tenover
et al., 1995), and multiple-locus variable-number tandem repeat
analysis (MLVA) (Sabat et al., 2003). Basedon molecular typing,
MRSA strains can be divided into various clones, usually denoted
by their MLST sequence type (ST) or clonal complex (CC),
followed by the SCCmec type. Some of these, for example CC8-
MRSA-IV (USA300 clone) and CC30-MRSA-IV (Southwest
Pacific clone) strains, appear to be pandemic, and have been
found on nearly every continent, while others, such as ST59-
MRSA-V (Taiwan clone) and ST80-MRSA-IV (European clone),
appear to be only regionally disseminated (Mediavilla et al.,
2012). In addition, virulence genes such as Panton-Valentine
leukocid in (PVL) gene lukF-PV and toxic shock syndrome
toxin gene tst-1, are often associated with certain S. aureus
clones, and can be used as additional genetic markers with which
to characterize MRSA strains. For example, lukF-PV has been
frequently found in isolates causing community infections, and
has traditionally been used as a surrogate maker for CA-MRSA.
By contrast, tst-1 appears to be limited to a handful of clonal
lineages, and is most frequently associated with methicillin-
susceptible S. aureus (MSSA) strains belonging to CC30, while
more recently, tst-positive CC5 and CC22 MRSA strains have
also been documented (Dauwalder et al., 2008; Al Laham et al.,
2015).
In China, a multi-drug resistant MRSA clone, defined as
ST239 by MLST, is now widely disseminated in different
geographic regions, accounting for >75% of all MRSA isolates in
two national studies (Liu et al., 2009; Chen et al., 2014). MRSA
ST239 strains usually harbor SCCmec type III elements, and
largely correspond to two spa types: t037 and t030. Interestingly,
recent studies demonstrated that spa t030 has displaced t037 and
has thereby become the most frequently-isolated MRSA spa type
in China (Chen et al., 2010). Second in prevalence following
ST239-MRSA-III is the ST5-MRSA-II clone, of which t002 is the
most commonly reported spa type (19). OtherMRSA clones, such
as ST398-MRSA-V (live stock-associated) and ST59-MRSA-IV
(community-associated), have also been identified (Chen et al.,
2010). Previous studies have shown that virulence genes lukF-
PV and tst-1 are rarely identified in ST239-MRSA-III and ST5-
MRSA-II strains in China. In this study, we report the spread
of tst-1-harboring ST5-MRSA-II isolates in a tertiary hospital
in Suzhou, Eastern China, with multivariate analysis further
demonstrating that presence of tst-1 is an independent risk factor
for 30-day mortality.
MATERIALS AND METHODS
Bacterial Isolates
A total of 150 MRSA isolates collected from February 2012
to May 2013 in a tertiary hospital in Suzhou, China, were
included. Identification of S. aureus isolates was performed using
standard microbiologic methods and the Phoenix System-100
BD Automated Microbiology system (BD Diagnostics, USA).
Presence of the mecA or mecC gene was determined by PCR as
described previously (Murakami et al., 1991; Stegger et al., 2012).
Antimicrobial Susceptibility
Isolates of S. aureus were inoculated onto the Phoenix panel
according to the manufacturer’s instructions, following which
species identification and antimicrobial susceptibility were
determined using the Phoenix System-100 BD Automated
Microbiology system (BD Diagnostics, USA). Results of
Minimum Inhibitory Concentrations (MICs) were recorded
according to Clinical and Laboratory Standards Institute
recommendations (CLSI, 2012). S. aureus ATCC 29213 was
used as a quality control strain for antimicrobial susceptibility
testing.
Molecular Typing
All 150 S. aureus isolates were characterized by staphylococcal
protein A (spa) typing (Shopsin et al., 1999), and spa types
were assigned using eGenomics software (Shopsin et al., 1999;
Mathema et al., 2008), with Ridom assignments made using
the Spa Server website (http://spa.ridom.de/). In order to avoid
confusion, eGenomics spa types were shown by the spa motif
repeats (e.g., spa type 2, TJMBMDMGMK), and Ridom spa
types shown as numbers (e.g., spa t030). All MRSA isolates
were subjected to SCCmec typing using multiplex real-time PCR
(Chen et al., 2009). MLST was performed as described previously
(Enright et al., 2000) on a representative subset of 30 isolates,
with clonal complexes inferred via eBURST analysis (Feil et al.,
2004); all other clonal complexes were inferred from spa typing
data as described previously (Mathema et al., 2008), using both
the Ridom Spa Server website and the eGenomics database.
Clonal complex sub-groups with distinct genotypic signatures
were classified as individual CCs (Mediavilla et al., 2012), e.g.,
ST239 strains were classified as CC239 rather than CC8. PFGE
and MLVA were performed as described previously (Tenover
et al., 1995; Sabat et al., 2003).
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Detection of PVL and TSST-1 Genes
All isolates were tested for the presence of the genes encoding
Panton-Valentine leukocid in (PVL) and toxic shock syndrome
toxin (TSST-1). The genes coding for PVL were detected by PCR
amplification of lukS-PV and lukF-PV (Said-Salim et al., 2005),
while the gene coding for TSST-1 was detected using a novel
real-time PCR assay reported elsewhere (Al Laham et al., 2015).
Clinical Information
For each patient diagnosed with MRSA infection, we recorded
demographics, comorbidities, patient location at isolation,
specimen source, antimicrobial therapies, vancomycin treatment
history, and 30-day mortality. Hospital-onset cases were defined
as positive culture occurring ≥3 days after hospitalization. The
study was approved by the Institutional Review Boards of the
Second Affiliated Hospital of Soochow University.
Statistical Analysis
Characteristics of patients in different groups were compared
using Chi-square or Fisher’s exact tests for categorical variables,
and Wilcoxon rank-sum test for continuous variables. P ≤
0.05 (two-tailed) were considered statistically significant. A
multivariable logistic regression model was constructed to
identify baseline factors independently associated with 30-day
mortality. All variables with P ≤ 0.1 in univariate analysis were
entered into the multivariable model and a backward stepwise
selection process was applied. SPSS, version 22.0 (IBM SPSS, IBM
Corporation, Somers, NY) was used for all statistical analyses.
Ethical Approval
The Medical Ethics Committee of Second Aﬄiated Hospital of
Soochow University approved this study and all isolates were
collected with the patients’ written informed consent.
RESULTS
Bacterial Isolates and Patient Data
A total of 150 unique MRSA isolates from different specimens,
collected from February 2012 to May 2013, were included
in this study. Among these, 71 were collected from internal
medicine wards (47.3%), 48 from surgical wards (32.0%), and 31
from intensive care unit (ICU) wards (20.7%). All isolates were
obtained from inpatients. 60% of patients were more than 60
years old, with an average age of 63, and 74.0% (n = 111) are
male. A total of 87.3% (n= 131) of the cases were hospital-onset.
The majority of the isolates were from sputum (n = 90, 60.0%),
followed by drainage (n= 17, 11.3%) and wounds (n= 12, 8.0%);
4 isolates were from blood, and 5 were from urine, while the
rest of the 22 isolates were from other sites. The Medical Ethics
Committee of Second Affiliated Hospital of Soochow University
approved this study and all isolates were collected with patient
consent in this study.
Antimicrobial Susceptibility
The antimicrobial resistance profiles for all 150MRSA isolates are
shown in Figure 1. All isolates were susceptible to vancomycin
and linezolid. The percentage of resistance to both penicillin
and oxacillin were 100.0% (150/150), while resistant tocefoxitin,
piperacillin-tazobactam, ampicillin-sulbactam, ciprofloxacin,
nitrofuantoin, erythromycin, clindamycin, trimethoprim-
sulfame thoxazole, and rifampin were 94.0% (141/150), 98.0%
(147/150), 66.0% (99/150), 64.0% (96/150), 60.0% (90/150),
74.0% (111/150), 50.0% (75/150), 72.0% (108/150), and 12.7%
(19/150), respectively.
Molecular Characteristics of MRSA
Among the 150 MRSA isolates, four SCCmec types were
identified, including types II (50, 33.3%), III (32, 21.3%), IV
(35, 23.3%), and V (32, 21.3%), while1 isolate (0.7%) was non-
typeable (NT) (Table 1). A total of 28 spa types were identified
among the 150 MRSA isolates, belonging to 11 CCs according
to eBURST analysis. CC5 isolates were the most common,
accounting for nearly one-third (48, 32.0%) of total isolates,
followed by CC239 (32, 21.3%), CC59 (19, 12.7%), CC88 (18,
12.0%), CC8 (15, 10.0%), and CC398 (13, 8.7%). One isolate each
of CC1, CC7, CC9, CC15, and CC72 was also identified.
Themost common spa type was t002(29.3%, 44/150), followed
by t037(14.7%, 22/150), t437(11.3%, 17/150), t4549(8.0%,
12/150), t3155(4.7%, 7/150), t034(4.0%, 6/150), and t571(3.3%,
5/150), while spa t030 was only found in 5 isolates (3.3%).
The two predominant genotypes were (a) CC5, spa type t002,
and SCCmec II (n = 42, 28.0%), and (b) CC239, spa t037, and
SCCmec III (n= 22, 14.7%).
Prevalence of pvl and tst-1
Among the 150 MRSA isolates, 11.3% (17/150) tested positive
for the presence of the genes coding for PVL (lukF-PV, lukS-
PV). PVL-positive isolates were identified in six different clonal
complexes (Table 1), including CC5, 8, 59, 88, 239, and 398.The
two most common spa types among PVL-positive isolates were
t437 (5/17, CC59) and t002 (4/17, CC5). Among these, 6 (35.3%),
5 (29.4%), and 4 (23.5%) isolates were classified as SCCmec type
IV, II, and V, respectively.
Similarly, 18.0% of the MRSA isolates (27/150) tested positive
for the presence of the TSST-1 gene(tst-1), which was detected
predominantly in CC5 (n = 26, 96.3%); the other tst-1-positve
isolate belonged to CC88. All the tst-1-positve CC5 isolates
were spa t002. Among the 26 tst-1-positive CC5-t002 isolates,
25 were SCCmec typeII and 1 isolate was type IV. PFGE and
MLVA both showed that these tst-positive CC5-t002 isolates
have indistinguishable pulsotypes and MLVA patterns (data not
shown), suggesting clonal spread.
Outcome and Risk Factors
In this study, 18 patients died within 30 days of hospitalization,
and the in-hospital 30-day mortality was 12.0%. We then
compared the outcomes, clinical characteristics, and MRSA
isolate genotypes within three major CCs (CC5, CC239, and
CC59) (Table 2). In comparison to cases infected with CC239
or CC59 strains, patients with CC5 infections had significantly
higher 30-day mortality (P < 0.05). In addition, CC5 strains had
a higher frequency of SCCmec type II and tst-1(P < 0.01), and
were more likely to be isolated from patients admitted to an ICU
(P < 0.05) (Table 2).
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FIGURE 1 | Antimicrobial resistance rate of 150 MRSA isolates
We then compared the clinical and molecular characteristics
between patients with different clinical outcomes (survival vs.
death) (Table 3). The following factors were associated with 30-
day mortality in univariate analysis: age, cancer, erythromycin
resistance, belonging to CC5, harboring SCCmec II, spa t002, and
presence of tst-1 (P< 0.05). In addition, ICU admission displayed
border line significance (P = 0.06). Notably, observed 30-day
mortality in patients with tst-1-positive MRSA was significantly
higher than that inpatient with tst-1-negative MRSA (51.9 vs.
3.3%, P < 0.001). By contrast, no significant difference in 30-
day mortality was observed between PVL-positive vs.-negative
groups (0.0 vs. 13.5%, P= 0.13). In multivariable analysis, factors
independently associated with 30-day mortality included age
greater than 60 years old (odds ratio [OR]= 7.2, 95% confidence
interval [95% CI] = 1.26–41.6, P = 0.026), cancer diagnosis (OR
= 9.6, 95% CI = 1.4–65.7, P = 0.02), and MRSA isolate carriage
of tst-1 (OR= 62.5, 95% CI= 12.0–325.2, P < 0.001).
DISCUSSION
MRSA is a major nosocomial pathogen worldwide. Infection
due to MRSA imposes a high and increasing burden on health
care resources, as well as increasing morbidity and mortality.
Several major MRSA clones are spreading globally, and they
often harbor virulence factors including PVL and TSST-1. Here
we characterized 150 non-duplicated MRSA clinical isolates
collected from a tertiary hospital in Suzhou, Eastern China. The
overall 30-day mortality was as high as 12%. Risk factors for
mortality were examined and we found that presence of tst-1, age
greater than 60 years, and underlying cancer co-morbidity were
independent risk factors associated with mortality.
This study revealed some interesting findings. Firstly, CC5
isolates were the main CC in our study, accounting for nearly one
third (48, 32.0%) of the total isolates, with the major genotype
identified consisting of CC5, spa type t002, and SCCmec type II
(42/150, 28.0%). By contrast, several studies have demonstrated
that CC239 is the predominant CC in China, associated with
SCCmec type III and mainly comprised of spa types t037 and
t030. A large survey screening a total of 702 MRSA isolates from
18 teaching hospitals in 14 Chinese cities between 2005 and 2006
showed that that the CC239 spa type t030 comprised 52.0% of
the total isolates, whilet037 accounted for 25.5% (Liu et al., 2009).
In addition, the distribution of spa types varied among different
regions, with t002 (CC5) the most common in northern cities,
t037 (CC239) predominant in eastern cities (e.g., Shanghai), and
t030 (CC239) the most common in other cities (Liu et al., 2009).
Another investigation highlighted a clonal shift from spa t037
(from 1994 to 2000) to spa t030 (since2000) as the major clone
in a Beijing hospital. Similarly, a recent study involving seven
hospitals in China showed an increasing prevalence of spa type
t030, with 80.1% of all MRSA isolates belonging to t030 (Chen
et al., 2014). The above studies suggest that ST239 spa t030 has
replaced t037, which represents the ancestral CC239 spa type, as
the most frequent MRSA spa type in China (Liu et al., 2009; Chen
et al., 2010, 2014). By contrast, CC5 spa t002 emerged initially in
2002, but has subsequently exhibited a low prevalence rate (Chen
et al., 2010). However, our study suggests that this may not be the
case in all institutions.
The current study was conducted in Suzhou, which is the
largest city near Shanghai, located∼60 miles away. Interestingly,
our study showed that t002 was the most common spa type
in our hospital, whereas over 70% isolates in Shanghai were
typed as t037 (Liu et al., 2009). Although located in a similar
geographic region, the epidemic pattern of CC and spa types
in our city was different from that of Shanghai. In addition,
our results showed that t037 (16.1%) was more common than
t030 (3.6%), which appears to be inconsistent with the pattern
of replacement of spa t037 by t030 in other studies (Liu et al.,
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TABLE 1 | Molecular characteristics of MRSA isolates.
Clonal complex spa type(Ridom) spa repeats (eGenomics) SCCmec* lukSF-Pv tst-1* No. of isolates
CC1 t127 UJFKBPE NT 1
CC5 t002 TJMBMDMGMK II + 25
t002 TJMBMDMGMK II + 4
t002 TJMBMDMGMK II 13
t002 TJMBMDMGMK IV + 1
t002 TJMBMDMGMK IV 1
t688 TJMBMK IV + 2
t688 TJMBMK IV 1
t2460 TMBBMDMMMK IV 1
CC7 t091 UJFMBGJAGJ II 1
CC8 t377 ZAGFMBLO II 1
t4223 ZFMBLO V 1
t4549 ZBFMFMBLO V 12
new ZBMBLO III + 1
CC9 t4132 UKKJAB V 1
CC15 t085 UJGBBGJAGJ II 1
CC59 t163 ZDMDMA3KB IV 1
t437 ZDMDMOB II 1
t437 ZDMDMOB IV 10
t437 ZDMDMOB IV + 2
t437 ZDMDMOB V 2
t437 ZDMDMOB V + 3
t519 ZDMO IV 1
CC72 t324 UJGGMDMGGM IV 1
CC88 t1764 UGFMEEBBBBPE V 1
t2310 UGFMEBBBBPE IV + 1
t2592 UGFMEEBBBPE IV + 1
t2592 UGFMEEBBBPE IV 1
t3155 UGFMEBBPE IV 7
t5348 UFMEEBBBPE IV + 1
t5348 UFMEEBBBPE IV 2
t7637 UGFMEEEBBBBPE II 1
t8296 UGFMBEBBBPE II + 1
t8296 UGFMBEBBBPE IV 2
CC239 t030 WGKAQQ III 5
t037 WGKAOMQ III + 1
t037 WGKAOMQ III 21
t459 WGKAQ III 2
t632 XKAQQ III 2
unknown WFFFGKAOMQ III 1
CC398 t034 XKAOAOBQO V + 1
t034 XKAOAOBQO V 5
t571 XKAOAOBO V 5
unkown XAOAOBQ V 2
*“+”, positive byPCR. NT, non-typeable.
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TABLE 2 | Clinical characteristics and MRSA genotypes of cases with
CC5, CC239 and CC59 infections.
CC5 CC239 CC59
Number of isolates 48 33 19
DEMOGRAPHICS
Age 65 (59–70) 63 (56–70) 50 (39–61)*
Male gender 38 (79.2) 24 (72.7) 16 (84.2)
UNDERLYING DISEASE
Cerebrovascular disease 10 (20.8) 3 (9.1) 5 (26.3)
Cancer 6 (12.5) 4 (12.1) 0 (0.0)
Respiratory infections 13 (27.1) 8 (24.2) 5 (26.3)
Blood stream infections 2 (4.2) 1 (3.0) 1 (5.3)
Degenerative diseases 7 (14.6) 3 (9.1) 1 (5.3)
Burns 0 (0.0) 2 (6.1) 1 (5.3)
Urinary Tract Infections 1 (2.1) 0 (0.0) 1 (5.3)
ICU admission 18 (37.5) 5 (15.2)* 2 (10.5)*
Hospital onset 45 (93.8) 30 (90.9) 16 (84.2)
SPECIMEN
Sputum 30 (62.5) 21 (63.6) 12 (63.2)
Drainage 5 (10.4) 3 (9.1) 1 (5.3)
Wound 0 (0.0) 2 (10.5)* 5 (15.2)
ANTIMICROBIAL RESISTANCE
Penicillin 48 (100.0) 33 (100.0) 19 (100.0)
Vancomycin 0 (0.0) 0 (0.0) 0 (0.0)
Linezolid 0 (0.0) 0 (0.0) 0 (0.0)
Erythromycin 45 (93.8) 32 (97.0) 10 (52.6)*
Clindamycin 27 (56.3) 25 (75.8) 8 (42.1)
TMP-SMX 44 (91.7) 27 (81.8) 10 (52.6)
Rifampin 34 (70.8) 15 (45.5) 10 (52.6)
Cefoxitin 47 (97.9) 33 (100.0) 16 (84.2)
Nitrofuantoin 21 (43.8) 20 (60.6) 5 (26.3)
Ciprofloxacin 47 (97.9) 25 (75.8) 18 (94.7)
STRAIN GENOTYPING
SCCmec type
SCCmec II 42 (87.5) 0 (0.0)* 1 (5.3)*
SCCmec III 0 (0.0) 33 (100.0)* 0 (0.0)
SCCmec IV 6 (12.5) 0 (0.0) 13 (68.4)*
SCCmec V 0 (0.0) 0 (0.0) 5 (26.3)*
PVL-positive 6 (12.5) 2 (6.1) 5 (26.3)
tst-1-positive 26 (54.2) 0 (0.0)* 0 (0.0)*
Outcome (death) 14 (29.2) 3 (9.1)* 1 (5.3)*
*P < 0.05 in comparison to CC5 group. Values are expressed in N (%) or mean (95%
confidence interval).
2009; Chen et al., 2010, 2014). Our results therefore suggest
differences in geographic distribution of MRSA clones within
Chinese hospitals. Specifically, the predominance of CC5 isolates
in our hospital is largely due to the high frequency of tst-1-
positive CC5-MRSA-II, spa t002 strains (Table 1).
The CC5 strains in this study have been largely associated with
tst-1, a gene encoding the toxic shock syndrome toxin TSST-1. In
this study, we found that 18.0% (n= 27) of allMRSA isolates were
tst-1-positive, with all but one belonging to CC5. However, tst-1
is rarely identified in CC5 MRSA strains in China. In a previous
TABLE 3 | Clinical characteristics and outcomes of cases with MRSA
infections.
Characteristics Survival (n = 132) Death (n = 18) P
DEMOGRAPHICS
Age 60 (57–64) 76 (68–83) 0.003
Male gender 98 (74.2) 13 (72.2 1.00
UNDERLYING DISEASE
Cerebrovascular disease 25 (18.9) 4 (22.2) 0.47
Cancer 11 (8.3) 5 (27.8) 0.01
Respiratory infections 30 (22.7) 7 (38.9) 0.15
Blood stream infections 6 (4.5) 0 (0.0) 0.63
Degenerative diseases 10 (7.6) 2 (11.1) 0.64
Burns 5 (3.8) 0 (0.0) 0.63
Urinary Tract Infections 4 (3.0) 0 (0.0) 1.00
ICU admission 24 (18.2) 7 (38.9) 0.06
Hospital onset 115 (87.1) 16 (88.9) 1.00
Vancomycin treatment 31 (23.5) 5 (27.8) 0.77
ANTIMICROBIAL RESISTANCE
Erythromycin 95 (72) 17 (94.4) 0.044
Clindamycin 67 (50.8) 12 (66.7) 0.21
TMP-SMX 95 (72) 15 (83.3) 0.40
Rifampin 77 (58.3) 12 (66.7) 0.50
Cefoxitin 124 (93.9) 17 (94.4) 1.00
Nitrofuantoin 57 (43.2) 7 (38.9) 0.73
Ciprofloxacin 115 (87.1) 16 (88.9) 1.00
STRAIN GENOTYPING
Clonal complex
CC5 34 (25.8) 14 (77.8) <0.001
CC239 30 (22.7) 3 (16.7) 0.76
CC398 13 (9.8) 0 (0.0) 0.23
CC59 18 (13.6) 1 (5.6) 0.47
CC88 18 (13.6) 0 (0.0) 0.13
SCCmec TYPE
SCCmec II 37 (28.0) 13 (72.2) <0.001
SCCmec III 29 (22.0) 3 (16.7) 0.77
SCCmec IV 34 (25.8) 1 (5.6) 0.07
SCCmec V 31 (23.5) 1 (5.6) 0.12
Spa TYPE
t002 30 (22.7) 14 (77.8) <0.001
t037 20 (15.2) 2 (11.1) 0.75
t437 16 (12.1) 1 (5.6) 0.49
PVL-positive 17 (12.9) 0 (0.0) 0.13
tst-1-positive 13 (9.8) 14 (77.8) <0.001
Values are expressed in N (%) or mean (95% confidence interval). Significant P-values are
shown in boldface.
multicenter study from China, tst-1 was detected in 31.4% of
isolates tested (including both MSSA and MRSA), but mostly in
CC398, CC15, and CC188 (He et al., 2013). Another study from
a city in central China has found tst-1 is mostly associated with
CC398, CC59, and CC8, but not CC5 (Liu et al., 2015). Moreover,
a recent study from another hospital in Suzhou, the same city
as in our study, also reported CC5 as the predominant MRSA
genotype, accounting for 50% of all MRSA isolates; however,
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none of the strains possessed tst-1 (Li et al., 2015). It appears
therefore that tst-1-harboring CC5 strains are an emerging clone
in our hospital. Alarmingly, our study showed that tst-1 is an
independent risk factor associated with 30-day mortality. The
mortality of patients infected by tst-1-positive MRSA strains
was much greater than that of patients infected by tst-negative
strains (51.8 vs. 3.5%, P < 0.01). Our findings therefore suggest
that, in our hospital, tst-1-positive CC5-MRSA-II- isolates may
be more virulent. Conversely, the presence of another virulence
factor, PVL, was not associated with increased mortality. In this
study, none of the 17 patients infected by PVL-positive strains
died. PVL is commonly found in CA-MRSA strains, and has
been associated with severe hospital-acquired pneumonia with
increased mortality (Vandenesch et al., 2003; Zhang et al., 2016).
However, our results are similar to those of other recent studies
of MRSA which did not observe an association between the
presence of PVL genes and increased mortality (Peyrani et al.,
2011; Haque et al., 2012; Tadros et al., 2013).
Our study had several limitations. Firstly, this study is limited
due to the relatively small sample size death cases, which is
reflected by the wide range of some confidence intervals in
multivariable analysis. Secondly, most of the isolates (60%)
were collected from sputum, which is over-represented in
the current study. Thirdly, we only tested for the presence
of two virulence factors (PVL and TSST-1) while evaluating
their associations with outcomes. Therefore, it is possible
that other virulence factors co-harbored along with tst-1 may
contribute to the increased mortality observed in the current
study. Lastly, this study lacks detailed information about the
underlying cause of death, partially due to the nature of
retrospective data collection, therefore we were not able to
determine the disease specific mortality but total mortality.
Nevertheless, our study revealed unique MRSA dissemination
patterns in our hospital. The finding that tst-1-positive CC5
strains were associated with higher total mortality highlights
the need for strict infection control measures in order to
prevent further spread of these strains in our hospital, as well
as others. Further genome-based analysis of tst-1-positive CC5
strains should also be performed to identify additional virulence
factors contributing to the high mortality observed in this
study.
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